These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Molecular pathology and detection of beta-thalassemias.
    Author: Cao A, Murru S.
    Journal: Prog Clin Biol Res; 1989; 309():3-11. PubMed ID: 2675099.
    Abstract:
    In this review, we have described the molecular bases accounting for beta, delta beta and gamma delta beta-thalassemias, discussed the molecular mechanisms responsible for the production of mild forms of thalassemia and presented a strategy for detecting beta-thalassemia mutations in each at risk population. The molecular bases of beta-thalassemia are very heterogeneous. The great majority of beta-thalassemias are caused by point mutations affecting the coding region or critical areas of the beta-globin gene and are only rarely produced by gross gene rearrangements. By contrast delta beta and gamma delta beta-thalassemias most commonly result from gross gene deletion. Determinants recognized to date as able to produce mild forms of beta-thalassemias, are beta-thalassemia mutations with a high residual output of beta-globin chain production, coinheritance of alpha-thalassemia or nondeletion HPFH linked or not linked to the beta-globin gene cluster, delta beta thalassemias and specific beta-globin haplotype. Because in each population a restricted number of molecular defect occurs, strategies have been developed to detect the beta-thalassemia mutations in prospective parents in each at risk population. These strategies are based on the direct detection of the mutation by dot blot analysis on enzymatically amplified DNA using a limited number of oligonucleotide probes complementary to the most common mutations in each population.
    [Abstract] [Full Text] [Related] [New Search]